367 related articles for article (PubMed ID: 19390205)
21. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
Shimizu A; Takei T; Uchida K; Tsuchiya K; Nitta K
Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
[TBL] [Abstract][Full Text] [Related]
22. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Amemiya N; Ochi A; Tsuruta Y; Shimizu A; Itabashi M; Takei T; Uchida K; Nitta K
Am J Nephrol; 2011; 34(3):233-40. PubMed ID: 21778707
[TBL] [Abstract][Full Text] [Related]
23. [Study on the predictors for superimposed preeclampsia in patients with IgA nephropathy].
Suetsugu Y; Tokudome G; Sugano N; Yoshizawa T; Endo S; Hara Y; Takane K; Kuriyama S; Hosoya T
Nihon Jinzo Gakkai Shi; 2011; 53(8):1139-49. PubMed ID: 22351992
[TBL] [Abstract][Full Text] [Related]
24. Effect of degree of obesity on renal transplant outcome.
Cacciola RA; Pujar K; Ilham MA; Puliatti C; Asderakis A; Chavez R
Transplant Proc; 2008 Dec; 40(10):3408-12. PubMed ID: 19100400
[TBL] [Abstract][Full Text] [Related]
25. A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study.
Wakai K; Kawamura T; Endoh M; Kojima M; Tomino Y; Tamakoshi A; Ohno Y; Inaba Y; Sakai H
Nephrol Dial Transplant; 2006 Oct; 21(10):2800-8. PubMed ID: 16822793
[TBL] [Abstract][Full Text] [Related]
26. [IgA nephropathy].
Alamartine E
Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
[TBL] [Abstract][Full Text] [Related]
27. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[TBL] [Abstract][Full Text] [Related]
28. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients.
Shen P; He L; Li Y; Wang Y; Chan M
Nephron Clin Pract; 2007; 106(4):c157-61. PubMed ID: 17596724
[TBL] [Abstract][Full Text] [Related]
29. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy.
Abe S
Clin Nephrol; 1994 Feb; 41(2):61-4. PubMed ID: 8004830
[TBL] [Abstract][Full Text] [Related]
30. [An IgA nephropathy case with highly reduced urinary protein concomitant with reduced obesity].
Nakamura T; Fujikura Y; Suga N; Hatazoe K; Hinoshita F
Nihon Jinzo Gakkai Shi; 2006; 48(7):675-9. PubMed ID: 17128885
[TBL] [Abstract][Full Text] [Related]
31. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
32. Impact of obesity in damage control laparotomy patients.
Duchesne JC; Schmieg RE; Simmons JD; Islam T; McGinness CL; McSwain NE
J Trauma; 2009 Jul; 67(1):108-12; discussion 112-4. PubMed ID: 19590318
[TBL] [Abstract][Full Text] [Related]
33. Primary IgA nephropathy with low histologic grade and disease progression: is there a "point of no return"?
Lai FM; Szeto CC; Choi PC; Li PK; Tang NL; Chow KM; Lui SF; Wong TY; Ho KK; To KF
Am J Kidney Dis; 2002 Feb; 39(2):401-6. PubMed ID: 11840383
[TBL] [Abstract][Full Text] [Related]
34. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
[TBL] [Abstract][Full Text] [Related]
35. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
Weber CL; Rose CL; Magil AB
Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
[TBL] [Abstract][Full Text] [Related]
36. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
[TBL] [Abstract][Full Text] [Related]
37. Immunoglobulin A nephropathy and chronic kidney disease.
Tomino Y
Nephrology (Carlton); 2010 Jun; 15 Suppl 2():23-6. PubMed ID: 20586943
[TBL] [Abstract][Full Text] [Related]
38. Podocyte lesions in patients with obesity-related glomerulopathy.
Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
[TBL] [Abstract][Full Text] [Related]
39. Pathological demography of native patients in a nephrology center in China.
Chen H; Tang Z; Zeng C; Hu W; Wang Q; Yu Y; Yao X; Wang J; Zhu M; Zhou H; Liu H; Liu Z; Li L
Chin Med J (Engl); 2003 Sep; 116(9):1377-81. PubMed ID: 14527370
[TBL] [Abstract][Full Text] [Related]
40. Renal disease in obesity: the need for greater attention.
Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
